Boston Scientific (BSX) Capital Expenditures (2009 - 2026)

Boston Scientific's Capital Expenditures history runs 18 years deep, the most recent figure standing at $177.0 million for Q1 2026.

• In Q1 2026, Capital Expenditures fell 5.35% year-over-year to $177.0 million; the TTM figure through Mar 2026 stood at $866.0 million (up 8.52% YoY), while the FY2025 annual figure was $876.0 million, up 10.89% from the prior year.
• Capital Expenditures came in at $177.0 million for Q1 2026 at Boston Scientific, down from $351.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $351.0 million in Q4 2025 to a low of $105.0 million in Q2 2022.
• A 5-year average of $184.8 million and a median of $179.0 million in 2024 frame the typical range for Capital Expenditures.
• On a YoY basis, Capital Expenditures climbed as much as 61.33% in 2022 and fell as far as 20.3% in 2022.
• Boston Scientific's Capital Expenditures stood at $212.0 million in 2022, then advanced by 25.94% to $267.0 million in 2023, then climbed by 3.75% to $277.0 million in 2024, then grew by 26.71% to $351.0 million in 2025, then sank by 49.57% to $177.0 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $177.0 million, $351.0 million, and $181.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison